

Preoperative bleeding risk assessment in cardiac surgery patients
https://doi.org/10.30629/0023-2149-2024-102-5-6-400-409
Abstract
One of the most important aspects in achieving successful outcomes in cardiac surgery is the evaluation of the risk of bleeding during and after the procedure. Preoperative anemia, intraoperative bleeding, and transfusion therapy contribute to a cumulative risk of adverse events. Given the limitations of traditional coagulation tests, a more comprehensive and patient-centered approach is necessary. Factors affecting the risk of bleeding should be considered from the perspective of both individual patient characteristics and the specific type and extent of the planned surgical intervention. The risk assessment should be informed by individual and familial history, as well as previous episodes of bleeding or other relevant information. The use of bleeding risk scales can play a crucial role in this process, providing valuable insights into the likelihood of bleeding complications. In conclusion, a comprehensive approach that takes into account the unique characteristics of each patient and the specific details of the surgical procedure is essential for minimizing the risk of complications and ensuring successful outcomes.
About the Author
V. S. ZyuzinRussian Federation
Vadim S. Zyuzin — doctor of the highest qualifi cation category, head of the transfusiological offi ce
Kaliningrad
References
1. Antwi-Kusi A., Addison W., Obasuyi B.I., Domoyeri P. Preoperative Laboratory Testing by Surgeons: Implication on Anaesthetic Management. International Journal of Clinical Medicine. 2019;10:345–52.
2. Martin S.K., Cifu A.S. Routine preoperative laboratory tests for elective surgery. JAMA. 2017:8:567–8.
3. Bohmer AB., Wappler F., Zwissler B. Preoperative Risk Assessment — From Routine Tests to Individualized Investigation. Dtsch. Arztebl. Int. 2014;111(25):437–46.
4. Liontos L., Fralick M., Longmore A. et al. Bleeding Risk Using INR.aPTT Pre-Surgery: Systematic Review (BRUISR). Blood. 2017;130(1):4654–4656.
5. Haas T., Fries D., Tanaka K.A. et al. Usefulness of standard plasma coagulation tests in the management of perioperative coagulopathic bleeding: is there any evidence? Br. J. Anaesth. 2015;114(2):217–224.
6. Curnow J., Pasalic L., Favaloro EJ. Why do patients bleed? Surg. J. (N.-Y.). 2016;2(1):29–43.
7. National Blood Authority. Preoperative Bleeding Risk Assessment Tool. Canberra ACT: National Blood Authority Australia. 2015.
8. Safiri S., Kolahi A.-A., Noori M. ,Nejadghaderi S.A., Karamzad N., Bragazzi N.L. et al. Burden of anemia and its underlying causes in 204 countries and territories, 1990–2019: results from the Global Burden of Disease Study 2019. J. Hematol. Oncol. 2021;14(1):185. DOI: 10.1186/s13045-021-01202-2
9. Healthcare in Russia. Ed. Smelov P.A. M., Stat. sat. Rosstat 2021:171. (In Russian)
10. Munting K.E., Klein A.A. Optimisation of pre‐operative anaemia in patients before elective major surgery – why, who, when and how? Anaesthesia. 2019;74(1):49–57.
11. http://uptodate.com.contents.perioperative-blood-management-strategies-to-minimize-transfusions
12. Idelson L.I., Vorobyov P.A. Iron deficiency anemia. A guide to hematology. ed. Vorobyova V.I. M., Newdiamed; 2005:171–190. (In Russian).
13. Cappellini M.D., Musallam K.M., Taher A.T. Iron deficiency anaemia revisited. J. Intern. Med. 2020;287(2):153–170.
14. Goddard A.F., James M.W., McIntyre A.S., Scott B.B. Guidelines for the management of iron deficiency anaemia. Gut. 2011;60:1309–1316.
15. Kudryashov A.A., Samoilova O.V., Samuilova D.S. Careful treatment of the patient’s blood as a priority strategy in cardiac surgery. Hematology and transfusiology. 2021;66(3):395–416. (In Russian). DOI: 10.35754.0234-5730-2021-66-3-395-416
16. Raphael J., Mazer C.D., Wilkey A. et al. Corrigendum to ‘Society of Cardiovascular Anesthesiologists (SCA) Clinical Practice Improvement (CPI) Advisory for Management of Perioperative Bleeding and Hemostasis in Cardiac Surgery Patients’ [Journal of Cardiothoracic and Vascular Anesthesia 2019;33:2887–2899]. J. Cardiothorac. Vasc. Anesth. 2020;34(3):840–841. DOI: 10.1053.j.jvca.2019.11.004
17. Estcourt L.J., Roberts D.J. Six-month outcomes after restrictive or liberal transfusion for cardiac surgery (TRICS III trial). Transfus. Med. 2019;29(2):77–79.
18. Leahy MF., Hofmann A., Towler S. et al. Improved outcomes and reduced costs associated with a healthsystem–wide patient blood management program: a retrospective observational study in four major adult tertiary-care hospitals. Transfusion. 2017;57(6):1347–1358.
19. https://uptodate.com.contents.preoperative-medical-evaluation-of-the-healthy-adult-patient
20. Zhang Q., Gao S., Diao X. et al. Dose-dependent influence of red blood cell transfusion volume on adverse outcomes in cardiac surgery. Perfusion. 2023;38(7):1436 –1443.
21. Shehata N., Mistry N., da Costa BR., Pereira T.V. et al. Restrictive compared with liberal red cell transfusion strategies in cardiac surgery: a meta-analysis. Eur. Heart J. 2019;40(13):1081–1088.
22. Stierer T.L., Collop N.A. Preoperative testing and risk assessment: perspectives on patient selection in ambulatory anesthetic procedures. Ambulatory Anesthesia. 2015;2:67–77.
23. Rydz N., James P.D. The evolution and value of bleeding assessment tools. J. Thromb. Haemost. 2012;10(11):2223–2229.
24. Han, Binru et al. Effects of the frailty phenotype on post-operative complications in older surgical patients: a systematic review and meta-analysis. BMC geriatrics. 2019;19(1):141. DOI: 10.1186.s12877-019-1153-8
25. Bennett J., Fung D., Hodson R., Agarwal A. Implementation of a Surgical Liaison Service for Elderly Patients: A Single Unit Experience. Geriatrics (Basel). 2019;4(3).
26. Fasulo M.R., Biguzzi E., Abbattista M. et al. The ISTH Bleeding Assessment Tool and the risk of future bleeding. J. Thromb. Haemost. 2018;16(1):125–130.
27. Elbatarny M., Mollah S., Grabell J. et al. Normal range of bleeding scores for the ISTH-BAT: adult and pediatric data from the merging project. Haemophilia. 2014;20(6):831–835.
28. National Blood Authority. Preoperative Bleeding Risk Assessment Tool. Canberra ACT, National Blood Authority Australia. 2015.
29. Adler M., Kaufmann J., Alberio L., Nagler M. Diagnostic utility of the ISTH bleeding assessment tool in patients with suspected platelet function disorders. J. Thromb. Haemost. 2019;17(7):1104–1112.
30. Curnow J., Pasalic L., Favaloro E.J. Why do patients bleed? Surg. J. (N.-Y.). 2016;2(1):29–43.
31. Spyropoulos A.C., Al-Badri A., Sherwood M.W., Douketis J.D. Periprocedural management of patients receiving a vitamin K antagonist or a direct oral anticoagulant requiring an electiveprocedure or surgery. J. Thromb. Haemost. 2016;14(5):875–885.
32.
Review
For citations:
Zyuzin V.S. Preoperative bleeding risk assessment in cardiac surgery patients. Clinical Medicine (Russian Journal). 2024;102(5-6):400-409. (In Russ.) https://doi.org/10.30629/0023-2149-2024-102-5-6-400-409